Bioxcel TherapeuticsBTAIQ
13F holders, Q1 2025 (March 31)31holders
$2.03avg. 13F price*
At the end of Q1 2025, 31 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings. The largest holders were Murchinson Ltd. ($276K), UBS Group AG ($207K) and Goldman Sachs Group Inc. ($50K).
- Company
- Bioxcel Therapeutics Inc.
- CUSIP
- 09075P204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $365K |
| Exits | 0 | $0 |
Ownership 31 holders
| Murchinson Ltd. | 0.05% | New | 136,076 | $276K |
| UBS Group AG | 0.00% | Add +28.1% | 101,778 | $207K |
| Goldman Sachs Group Inc. | 0.00% | New | 24,794 | $50K |
| BlackRock, Inc. | 0.00% | Reduce -1.8% | 23,241 | $47K |
| Geode Capital Management, LLC | 0.00% | Add +13.7% | 22,062 | $45K |
| Beacon Pointe Advisors, LLC | 0.00% | New | 18,845 | $38K |
| Vanguard Group Inc. | 0.00% | Reduce -74.5% | 18,824 | $38K |
| Wells Fargo & Company | 0.00% | Reduce -0.7% | 12,293 | $25K |
| Virtu Financial LLC | 0.00% | Add +909.6% | 10,666 | $22K |
| Barclays PLC | 0.00% | Add +34790.1% | 1,910 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +103.6% | 1,884 | $4K |
| Morgan Stanley | 0.00% | Add +10.1% | 1,766 | $4K |
| Bank of America Corp. | 0.00% | Reduce -53.9% | 1,519 | $3K |
| Group One Trading LLC | 0.00% | Add +13.0% | 1,273 | $3K |
| SBI Securities Co., Ltd. | 0.00% | Add +7.7% | 851 | $2K |
| Federated Hermes, Inc. | 0.00% | Reduce -20.9% | 237 | $481 |
| AllSquare Wealth Management LLC | 0.00% | New | 175 | $355 |
| Washington Trust Advisors, Inc. | 0.00% | No change | 160 | $325 |
| Tower Research Capital LLC (TRC) | 0.00% | Add +843.4% | 152 | $309 |
| JPMorgan Chase & Co. | 0.00% | Add +40.4% | 116 | $235 |
| Parkside Financial Bank & Trust | 0.00% | No change | 112 | $228 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | Add +0.2% | 103 | $209 |
| BNP Paribas Financial Markets | 0.00% | Reduce -69.5% | 44 | $89 |
| NewEdge Advisors, LLC | 0.00% | Reduce -0.3% | 31 | $63 |
| National Bank of Canada | 0.00% | Reduce -57.5% | 27 | $54 |
| Northwestern Mutual Wealth Management Co. | 0.00% | Reduce -0.7% | 21 | $43 |
| FMR LLC | 0.00% | New | 11 | $22 |
| Farther Finance Advisors, LLC | 0.00% | Reduce -15.4% | 5 | $10 |
| Danske Bank A/S | 0.00% | New | 3 | $6 |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -57.3% | 3 | $6 |
| US Bancorp \de | 0.00% | Reduce -51.3% | 1 | $2 |
"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.